Luigi Mangione to Use Psychiatric Defence in United Healthcare CEO Murder Trial
Mangione Announces Psychiatric Defence Ahead of Trial
Luigi Mangione will claim he acted under an "extreme emotional disturbance" when he allegedly shot Brian Thompson, CEO of United Healthcare, in December 2024. The strategy was disclosed to Judge Gregory Carro on Wednesday, signaling a shift from a traditional murder defence to a reduced‑responsibility claim.
Legal Basis of the Extreme Emotional Disturbance Claim
New York law permits defendants to argue that intense emotional turmoil at the time of the killing diminishes culpability, potentially lowering the charge from murder to manslaughter. Unlike an insanity plea, this defence admits the act but attributes it to impaired judgement.
Potential Sentencing Shift from Murder to Manslaughter
If the jury accepts the emotional‑disturbance argument, Mangione could face a manslaughter conviction, which typically carries a lighter prison term than the life‑sentence range associated with murder. In the parallel federal case, he already faces a possible life term on stalking and related charges.
Healthcare Pricing Anger Fuels Public Reaction
The killing sparked widespread outrage over "sky‑high" healthcare prices. Police noted the words “delay”, “deny”, and “depose” etched on Mangione’s ammunition, echoing public frustration with insurance claim denials.
Future Court Dates and Possible Outcomes
- State trial commencement: September 8, 2026
- Federal trial commencement: October 13, 2026
- Potential outcomes: manslaughter conviction with reduced sentence, or conviction on federal stalking charges carrying life imprisonment.
The case also highlights the legal limits on the death penalty in New York, as a prior ruling by U.S. District Judge Margaret Garnett removed that possibility.